camptothecin has been researched along with troxacitabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, YC; Dutschman, GE; Hsu, CH; Kim, TE; Park, SY | 1 |
Baker, SD; Chatelut, E; Mathijssen, RH; Rowinsky, EK; Sparreboom, A; Verweij, J; Wolff, AC | 1 |
2 other study(ies) available for camptothecin and troxacitabine
Article | Year |
---|---|
Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Cytosine; Deoxycytidine Kinase; Dioxolanes; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Humans; KB Cells; Tumor Cells, Cultured | 2004 |
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Mass Index; Body Size; Body Surface Area; Body Weight; Camptothecin; Carboplatin; Cisplatin; Cytosine; Dioxolanes; Docetaxel; Doxorubicin; Humans; Irinotecan; Metabolic Clearance Rate; Obesity; Paclitaxel; Taxoids; Topotecan | 2007 |